2 insider filings
Yariv Houvras, new insider at XLO
Show all 2
- 3New insider at XLO
- 4Insider filing for XLO
Yariv Houvras
XLO
Xilio Therapeutics, Inc. SEC filings
Every EDGAR filing for Xilio Therapeutics, Inc. (XLO), newest first, with AI summaries and stories.
- Ticker
- XLO
- CIK
- 1840233
- Latest filing
- Oct 2
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE3Xilio Therapeutics, Inc.XLOLIVE ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE NOTABLE10-QXilio Therapeutics, Inc.XLOLIVE ROUTINES-8Xilio Therapeutics, Inc.XLOLIVE ROUTINESCHEDULE 13G/AXilio Therapeutics, Inc.XLOLIVE Ownership stake disclosure by STEMPOINT CAPITAL LP (amended)
STEMPOINT CAPITAL LP, filed by
ROUTINE4Xilio Therapeutics, Inc.XLOLIVE 7 insider filings
Yuan Xu, insider filing for XLO
Show all 7
- 4Insider filing for XLO
- 4Insider filing for XLO
- 4Insider filing for XLO
- 4Insider filing for XLO
- 4Insider filing for XLO
- 4Insider filing for XLO
- 4Insider filing for XLO
Yuan Xu, reporting
ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINEEFFECTXilio Therapeutics, Inc.XLOLIVE ROUTINES-3/AXilio Therapeutics, Inc.XLOLIVE ROUTINESCHEDULE 13GXilio Therapeutics, Inc.XLOLIVE 3 13G filings
Ownership stake disclosure by ORBIMED ADVISORS LLC
Show all 3
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
ORBIMED ADVISORS LLC, filed by
ROUTINESCHEDULE 13GXilio Therapeutics, Inc.XLOLIVE Ownership stake disclosure by Sirenia Capital Management LP
Sirenia Capital Management LP, filed by
ROUTINES-3Xilio Therapeutics, Inc.XLOLIVE NOTABLE10-QXilio Therapeutics, Inc.XLOLIVE ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINEARSXilio Therapeutics, Inc.XLOLIVE ROUTINEDEF 14AXilio Therapeutics, Inc.XLOLIVE ROUTINE4Xilio Therapeutics, Inc.XLOLIVE 2 insider filings
Cheryl R Blanchard, insider filing for XLO
Show all 2
- 4Insider filing for XLO
- 3New insider at XLO
Cheryl R Blanchard, reporting
ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINE4Xilio Therapeutics, Inc.XLOLIVE James Samuel Shannon, insider filing for XLO
James Samuel Shannon, reporting
ROUTINES-8Xilio Therapeutics, Inc.XLOLIVE NOTABLE10-KXilio Therapeutics, Inc.XLOLIVE ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINE4Xilio Therapeutics, Inc.XLOLIVE GILEAD SCIENCES, INC., insider filing for XLO
GILEAD SCIENCES, INC., reporting
ROUTINESCHEDULE 13G/AXilio Therapeutics, Inc.XLOLIVE Ownership stake disclosure by Bain Capital Life Sciences Fund II, L.P. (amended)
Bain Capital Life Sciences Fund II, L.P., filed by
ROUTINESCHEDULE 13G/AXilio Therapeutics, Inc.XLOLIVE Ownership stake disclosure by STEMPOINT CAPITAL LP (amended)
STEMPOINT CAPITAL LP, filed by
ROUTINESCHEDULE 13G/AXilio Therapeutics, Inc.XLOLIVE Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P. (amended)
Frazier Life Sciences Public Fund, L.P., filed by
ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINE424B5Xilio Therapeutics, Inc.XLOLIVE ROUTINESCHEDULE 13G/AXilio Therapeutics, Inc.XLOLIVE Ownership stake disclosure by GILEAD SCIENCES, INC. (amended)
GILEAD SCIENCES, INC., filed by
ROUTINE424B5Xilio Therapeutics, Inc.XLOLIVE ROUTINEDEF 14AXilio Therapeutics, Inc.XLOLIVE ROUTINEPRE 14AXilio Therapeutics, Inc.XLOLIVE ROUTINE8-KXilio Therapeutics, Inc.XLOLIVE ROUTINE4Xilio Therapeutics, Inc.XLOLIVE 4 insider filings
Christopher James Frankenfield, insider filing for XLO
Show all 4
- 4Insider filing for XLO
- 4Insider filing for XLO
- 4Insider filing for XLO
- 4Insider filing for XLO
Christopher James Frankenfield, reporting